SHBG and polycystic ovary syndrome: Statins also lower dehydroepiandrosterone (DHEA) and sex hormone-binding globulin (SHBG), influencing the hormonal environment and potentially reducing cancer risk, particularly in women with polycystic ovary syndrome (PCOS) [43,44,45,46].